Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

23.05
Delayed Data
As of Feb 27
 +0.75 / +3.36%
Today’s Change
6.28
Today|||52-Week Range
24.00
+54.70%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close22.30
Today’s open22.30
Day’s range22.10 - 24.00
Volume547,931
Average volume (3 months)148,994
Market cap$776.0M
Dividend yield--
Data as of 3:59pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)-9.51%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc+0.25+2.20%
ACRSAclaris Therapeutics...+1.28+4.16%
AKAOAchaogen Inc+0.03+0.13%
HRTXHeron Therapeutics I...+1.25+8.99%
Data as of 4:00pm ET, 02/27/2017

Financials

Last reporting dateFebruary 21, 2017
EPS forecast (this quarter)-$0.84
Annual revenue (last year)$0.00
Annual profit (last year)-$95.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs